Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses - PubMed (original) (raw)
Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses
H Nishimura et al. Int Immunol. 1998 Oct.
Abstract
PD-1, an Ig superfamily member, contains an immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic tail. It is expressed in a minor fraction of CD4-CD8- normal thymocytes and induced in peripheral lymphocytes following activation. To assess the possible roles of PD-1 in the immune responses, PD-1-deficient (PD-1-/-) mice were generated by a gene-targeting strategy. PD-1-4- mice developed and grew normally. Although the thymus was apparently normal, PD-1-/- mice showed moderate but consistent splenomegaly, which reflected the increased cellularity of both lymphoid and myeloid cells. The proliferative response of B cells by anti-IgM antibodies, but not of T cells by an anti-CD3 (145-2C11) mAb in vitro, was augmented in PD-1-/- mice as compared with control littermates. PD-1-/- mice showed increased serum levels of IgG2b, IgA and most strikingly IgG3, while those of IgM and IgG1 were comparable with control mice. Furthermore, PD-1-/- mice exhibited significantly augmented IgG3 anti-DNP antibody response to a type 2 T-independent antigen, DNP-Ficoll, with comparable IgM and IgG1 antibody responses with littermate controls. In the peritoneal cavity, the B-1 cell population in PD-1-/- mice exhibited significantly reduced expression of CD5, a negative regulator of B-1 cell activation, despite a marginal increase in the number of B-1 cells. Thus, PD-1 was suggested to be involved in the negative regulation for particular aspects of B cell proliferation and differentiation including class switching.
Similar articles
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.
Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Agata Y, et al. Int Immunol. 1996 May;8(5):765-72. doi: 10.1093/intimm/8.5.765. Int Immunol. 1996. PMID: 8671665 - Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes.
Nishimura H, Agata Y, Kawasaki A, Sato M, Imamura S, Minato N, Yagita H, Nakano T, Honjo T. Nishimura H, et al. Int Immunol. 1996 May;8(5):773-80. doi: 10.1093/intimm/8.5.773. Int Immunol. 1996. PMID: 8671666 - PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM. Carter L, et al. Eur J Immunol. 2002 Mar;32(3):634-43. doi: 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9. Eur J Immunol. 2002. PMID: 11857337 - Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F. Rolink AG, et al. Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review. - CD72, a negative regulator of B-cell responsiveness.
Parnes JR, Pan C. Parnes JR, et al. Immunol Rev. 2000 Aug;176:75-85. doi: 10.1034/j.1600-065x.2000.00608.x. Immunol Rev. 2000. PMID: 11043769 Review.
Cited by
- Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.
Soussan S, Pupier G, Cremer I, Joubert PE, Sautès-Fridman C, Fridman WH, Sibéril S. Soussan S, et al. Front Immunol. 2024 Jan 22;15:1343020. doi: 10.3389/fimmu.2024.1343020. eCollection 2024. Front Immunol. 2024. PMID: 38318190 Free PMC article. Review. - Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.
Green KA, Cook WJ, Green WR. Green KA, et al. J Virol. 2013 Feb;87(4):2058-71. doi: 10.1128/JVI.01547-12. Epub 2012 Dec 5. J Virol. 2013. PMID: 23221564 Free PMC article. - Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis.
Kalinoski H, Daoud A, Rusinkevich V, Jurčová I, Talor MV, Welsh RA, Hughes D, Zemanová K, Stříž I, Hooper JE, Kautzner J, Peichl P, Melenovský V, Won T, Čiháková D. Kalinoski H, et al. Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2323052121. doi: 10.1073/pnas.2323052121. Epub 2024 Oct 8. Proc Natl Acad Sci U S A. 2024. PMID: 39378095 - Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.
Frebel H, Nindl V, Schuepbach RA, Braunschweiler T, Richter K, Vogel J, Wagner CA, Loffing-Cueni D, Kurrer M, Ludewig B, Oxenius A. Frebel H, et al. J Exp Med. 2012 Dec 17;209(13):2485-99. doi: 10.1084/jem.20121015. Epub 2012 Dec 10. J Exp Med. 2012. PMID: 23230000 Free PMC article. - Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.
Yonezawa N, Murakami H, Demura S, Kato S, Miwa S, Yoshioka K, Shinmura K, Yokogawa N, Shimizu T, Oku N, Kitagawa R, Handa M, Annen R, Kurokawa Y, Fushimi K, Mizukoshi E, Tsuchiya H. Yonezawa N, et al. Int J Mol Sci. 2021 Feb 17;22(4):1973. doi: 10.3390/ijms22041973. Int J Mol Sci. 2021. PMID: 33671258 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous